Overview of approved CAR-T products and utility in clinical practice
Shakthi Bhaskar, Bhagirathbhai Dholaria, Bipin N. Savani, Salyka Sengsayadeth, Olalekan O. Oluwole
Abstract
By Shakthi T Bhaskar, Bhagirathbhai Dholaria & 3 more. Since the first (CAR) T-cell product received FDA approval in 2017, studies have been completed that have led to approvals of CAR T-cells to treat a variety of malignancies.
Topics & Concepts
Clinical PracticeBusinessMedicinePsychologyFamily medicineCAR-T cell therapy researchBiomedical Ethics and RegulationBiosimilars and Bioanalytical Methods